Li R, Shah PH, Stewart TF, Nam JK, et al. Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nat Med 2024 Jun 6. doi: 10.1038/s41591-024-03025.
PMID: 38844794